The Valley Desk

NCT02588456 · Interventional trial

Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia

Overall registry status Terminated

Phase 1

Conditions Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov